Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Network San Marino.
Press releases published on July 28, 2025
EIN Presswire Debuts Podcast with PR Insider Sherrie Handrinos on the Power of Influencer Marketing
EIN Presswire
·
July 28, 2025
“Heard on the Streets” podcast explores how brands are cashing in on social media strategy WASHINGTON , DC, UNITED STATES, July 28, 2025 /EINPresswire.com/ -- EIN Presswire has launched its first audio podcast on Substack, and it’s diving into one of …
FDA Approves Apellis’ EMPAVELI® (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older
GlobeNewswire
·
July 28, 2025
Proven efficacy across all three key markers of disease—68% reduction in proteinuria, stabilization of kidney function, and substantial clearance of C3 deposits Broad label includes adults and adolescents with C3G or primary IC-MPGN, and post-transplant …
North Park Nursing Student Receives Prestigious Schweitzer Fellowship
GlobeNewswire
·
July 28, 2025
Chicago, July 28, 2025 (GLOBE NEWSWIRE) -- Victoria Roehl, a student in the Master of Nursing Leadership program at North Park University (NPU), has been named a 2025–26 Schweitzer Fellow, a prestigious honor given to graduate students to lead innovative, …
Strength Building: How Strength Training Supplements Help You Build Muscle Mass and Keep Growing Stronger - CrazyBulk
GlobeNewswire
·
July 28, 2025
New York City, NY, July 28, 2025 (GLOBE NEWSWIRE) -- Build muscle mass and keep growing stronger with CrazyBulk’s legal strength training supplements. Explore the best stacks for real power gains in 2025 In the evolving world of performance fitness, …
Regional Health Properties, Inc. Outlines Reasons for Regional Shareholders to Vote YES for Proposed Merger with SunLink Health Systems, Inc.
GlobeNewswire
·
July 28, 2025
ATLANTA, GA, July 28, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCBQ: RHEP) (OTCQB: RHEPA) (OTCQB: RHEPB), a self-managed healthcare real estate investment company that invests primarily in real estate purposed for senior …
Qualigen Therapeutics Provides Update on Nasdaq Communications and Continued Listing Status
GlobeNewswire
·
July 28, 2025
CARLSBAD, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) received two different communications from the staff of the Nasdaq Listing Qualifications office of the Nasdaq Stock Market, LLC. The Company …
Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering
GlobeNewswire
·
July 28, 2025
WOBURN, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- This press release corrects a version issued on July 25, 2025 that incorrectly listed KCSA Strategic Communications as iSpecimen’s investor relations contact. KCSA is not currently affiliated with iSpecimen …
Tilray Brands Reports Fourth Quarter and Fiscal 2025 Financial Results
GlobeNewswire
·
July 28, 2025
Fiscal Year Net Revenue of $821 Million, $834 Million in Constant Currency, Strategic Decisions Impacted Revenue by $35 Million Q4 Consolidated Adjusted EBITDA is the 2nd Highest in the Company’s History International Cannabis Revenue Increased 71% in Q4 …
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
GlobeNewswire
·
July 28, 2025
AMF Regulated Information Châtillon, France, July 28, 2025 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical …
Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025
GlobeNewswire
·
July 28, 2025
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced …
Abivax Announces Closing of $747.5 Million Public Offering
GlobeNewswire
·
July 28, 2025
Abivax Announces Closing of $747.5 Million Public Offering PARIS, France, July 28, 2025 – 10:15 p.m. (CEST) – Abivax SA (Euronext Paris: FR0012333284 – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing …
Dyne Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewswire
·
July 28, 2025
- Expected cash runway extended into Q3 2027, beyond multiple potential inflection points including Dyne’s first planned commercial launch in early 2027 - - Registrational Expansion Cohort of DELIVER Trial of DYNE-251 in DMD fully enrolled to support …
Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine
GlobeNewswire
·
July 28, 2025
Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine Mont-Saint-Guibert, Belgium – July 28, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology …
Roivant to Report Financial Results for the First Quarter Ended June 30, 2025, and Provide Business Update on Monday, August 11, 2025
GlobeNewswire
·
July 28, 2025
BASEL, Switzerland and LONDON and NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, August 11, 2025, to report its financial results for the …
Celcuity Inc. Announces Concurrent Public Offerings of Convertible Senior Notes Due 2031 and Common Stock
GlobeNewswire
·
July 28, 2025
MINNEAPOLIS, July 28, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (the “Company”), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced proposed underwritten public offerings of $150,000, …
Fulcrum Therapeutics to Present Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
GlobeNewswire
·
July 28, 2025
CAMBRIDGE, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Fulcrum) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare …
SonderCare Launches Certified Home Hospital Beds to Support 16 Million Middle-Income Seniors Facing Long-Term Care Crisis
GlobeNewswire
·
July 28, 2025
London, ON , July 28, 2025 (GLOBE NEWSWIRE) -- SonderCare, a leading manufacturer of home-based hospital beds, today announced expanded access to its certified premium home care beds to meet growing demand from the “missing middle”—the estimated 16 million …
How to Build Muscle Fast for Beginners And Skinny Guys: with CrazyBulk Legal Steroids for Muscle Endurance A Guide in 2025 For Bodybuilders Muscle Growth
GlobeNewswire
·
July 28, 2025
Los Angeles, CA, July 28, 2025 (GLOBE NEWSWIRE) -- For beginners looking to build muscle fast in 2025, achieving rapid growth involves more than just lifting weights. A proven combination of the right workout strategies, balanced nutrition, and effective …
Neurogen Biomarking Virtual Care Ecosystem Cuts Time to Alzheimer’s Intervention by 4.5 Years, AAIC 2025 Presentation Findings Show
GlobeNewswire
·
July 28, 2025
Progress in validating in-home blood test, combined with cognitive assessment and specialty virtual care, break through barriers to early detection Key Takeaways Findings from breakthrough approach to early detection for Alzheimer’s disease (AD) has the …
New Study Shows How to Change Trajectory of Cognitive Decline
GlobeNewswire
·
July 28, 2025
TORONTO, July 28, 2025 (GLOBE NEWSWIRE) -- Results from a large study announced today provides those with elevated Alzheimer’s risk a new path for changing the trajectory of their brain health. The researchers reported a significant improvement in global …